Biosimilars for breast cancer treatment - European Medical Journal

Continue

Biosimilars for breast cancer treatment

Oncology
At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Peter Schmid (Barts Cancer Institute, London, UK) discusses the key challenges in the manufacture, development and approval of biosimilars for breast cancer treatment.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given